guia_fractura_cadera
guia_fractura_cadera
guia_fractura_cadera
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
FRACTURA DE CADERA. Anciano afecto de <strong>fractura</strong> de <strong>cadera</strong><br />
144. Devine A, Dick IM, Heal SJ, Criddle RA, Prince RL. A 4-year follow-up of study of the effects<br />
of calcium supplementation on bone density in elderly postmenopausal women. Osteoporosis<br />
Int. 1997;7:23-8.<br />
145. Reid IR, Ames RW, Evans MC, Gamble GD, Sharp SJ. Long-term effects of calcium supplementation<br />
on bone loss and fractures in postmenopausal women: a randomised controlled<br />
trial. Am J Med. 1995;98:331-5.<br />
146. Bischoff-Ferrari HA, Willett WC, Wong JB, Giovannucci E, Dietrich T, Dawson-Hughes B.<br />
Fracture prevention with vitamin D supplementation: a meta-analysis of randomized controlled<br />
trials. JAMA. 2005;293:2257-64.<br />
147. Bischoff-Ferrari HA, Dawson-Hughes B, Willett WC, Staehelin HB, Bazemore MG, Zee RY, et<br />
al. Effect of vitamin D on falls: a meta-analysis. JAMA. 2004;291:1999-2006.<br />
148. Guillespie WJ, Henry DA, O’Connell DL, Robertson J. Vitamin D and vitamin D analogues for<br />
preventing fractures associated with involutional and postmenopausal osteoporosis. Cochrane<br />
Database Syst Rev. 2000;3:1-36.<br />
149. Chapuy MC, Arlot ME, Dubouef F, Brun J, Crouzet B, Arnaud S, et al. Vitamin D3 and calcium<br />
to prevent hip fractures in the elderly women. N Engl J Med. 1992;327:1637-42.<br />
150. Dawson-Hughes B, Harris SS, Krall EA, Dallal GE. Effect of calcium and vitamin D supplementation<br />
on bone density in men and women 65 years of age or older. N Engl J Med.<br />
1997;337:670-6.<br />
151. Gillespie WJ, Henry DA, O’Connell DL, Robertson J. Vitamin D and Vitamin D analogues for<br />
preventing fractures associated with involutional and postmenopausal osteoporosis (Cochrane<br />
Review). En: The Cochrane Library. Issue 1. Oxford: Update Software; 1999.<br />
152. Register JY, Seaman E, De Vernejoul S, Adami J, Comspton C, Phenekos JP, et al. Strontium<br />
ranelate reduces the risk of non vertebral fractures in postmenopausal women with osteoporosis:<br />
Treatment of Peripheral Osteoporosis (TROPOS) Study. J Clin Endocrinol Metab.<br />
2005;90:2816-22.<br />
153. Black DM, Cummings SR, Karpf DB, Cauley JA, Thompson DE, Mevitt MC, et al. Randomised<br />
trial of effect of alendronate on risk of fracture in women with existing vertebral fractures.<br />
Fracture Intervention Trial Research Group. Lancet. 1996;348;1535-41.<br />
154. Cummings SR, Black DM, Thompson DE, Applegate WB, Barrett-Connor E, Musliner TA, et<br />
al. Effect of alendronate on risk of fracture in women with low bone density but without vertebral<br />
fractures: results from the Fracture Intervention Trial. JAMA. 1998;280:2077-82.<br />
155. Black DM, Thompson DE, Bauer DC, Ensrud K, Musliner T, Hochberg MC, et al. Fracture risk<br />
reduction with alendronato in women with osteoporosis: the fracture intervention trial. FIT<br />
Research Group. J Clin Endocrinol Metab. 2000;85:4118-24.<br />
156. McClung MR, Geusens P, Miller PD, Zippel H, Bensen WG, Roux C, et al. Effect of risedronate<br />
on the risk of hip fracture in elderly women. N Engl J Med. 2001;344:333-40.<br />
157. Boonen S, McClung MR, Eastell R, Fuleihan GE, Barton IP, Delmas P. Safety and efficacy of<br />
risedronate in reducing fracture risk in osteoporotic women aged 80 and older: implications<br />
for the use of antiresortive agents in the old and oldest old. JAGS. 2004:52:1832-9.<br />
135
Change language